}

Tandem Diabetes Care Sponsors Snail Mail Club from Beyond Type 1 to Help Connect People with Type 1 Diabetes

 

San Diego, April 11, 2019  Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its sponsorship of the Beyond Type 1 Snail Mail Club. Percy, the official Snail Mail mascot, will begin using the t:slim X2™ insulin pump from Tandem Diabetes Care as part of the new partnership.

“Tandem Diabetes Care has always been impressed with the way Beyond Type 1 has supported people with diabetes, and their ongoing efforts to help people in the community connect with each other,” says John Sheridan, CEO of Tandem Diabetes Care. “We are excited to support this initiative, and we’re looking forward to hearing what Percy the Snail has to say about the t:slim X2 insulin pump.

Beyond Type 1’s Snail Mail Club is a pen pal program for people with type 1 diabetes around the world. Currently in 50 different countries with nearly 7,500 participants from 1 to 80 years old, the program offers a global community of support for those living with type 1 diabetes.

“Beyond Type 1's Snail Mail Program brings the magic of the type 1 community offline, connecting kids and families in an entirely different way. The idea for a pen pal club came straight from the community, and has grown into a program that connects thousands across every continent except Antarctica,” says Thom Scher, CEO of Beyond Type 1. “With Tandem's partnership, the Snail Mail Club can continue to grow, to connect even more children and families, and to remain 100% free. And of course, Percy the Snail is excited to get a new t:slim X2 pump too." 

Snail Mail Club subscribers receive a starter kit with everything needed to send four letters (if in the U.S.) or postcards (if outside of the U.S.) to a new Snail Mail Club Pen Pal. Each club member receives an information sheet with a brief bio to help write the first letter.

For more information about the Snail Mail Club, visit www.beyondtype1.org/snail-mail-club

Tandem Diabetes Care periodically provides sponsorships and grants for educational and empowerment programing in the diabetes community. Grants are awarded to qualified non-profit organizations with the mission to empower people with diabetes, and to assist local initiatives, events, and programing that support Tandem’s mission, its employees, and corporate citizenship.

About Beyond Type 1

Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. Through platforms, programs, resources, and grants, Beyond Type 1 is uniting the global diabetes community and providing solutions to improve lives today. Founded in 2015 with a focus on education, advocacy and the path to a cure for Type 1 diabetes, Beyond Type 1 has grown to also include programs for those with Type 2 diabetes. A new model of philanthropy, Beyond Type 1 aims to change what it means to live with chronic illness.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience.  The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring.  Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.

Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.

Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.

Tandem Diabetes Care is a trademark of Tandem Diabetes Care, Inc., registered in the U.S. and other countries. t:slim X2 is a trademark of Tandem Diabetes Care, Inc. All other third-party marks are the property of their respective owners.

Tandem Diabetes Care Contact Information:

Media: Steve Sabicer, 714-907-6264, ssabicer@thesabicergroup.com
Investors: Susan Morrison, 858-366-6900 x7005, IR@tandemdiabetes.com

Back to Feed